Landscapes / Companies
Teva Branded Pharmaceutical Products R&D LLC not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 3
2 in Phase 2
Drugs
5
in active trials · 11 in all
Trials
9 active
22 since 2021
Drugs5
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Teva Branded Pharmaceutical Products R&D |
Phase 3 | 31 Dec 2026Phase 3 trial completes | ||
| Next date | 31 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Asthma | ||||
| Open drug page | |||||
— |
Phase 2/3 | 12 Sep 2030Phase 2/3 trial completes | |||
| Next date | 12 Sep 2030 · Phase 2/3 trial completes | ||||
| Also tested for | Vitiligo, Celiac Disease | ||||
| Open drug page | |||||
— |
Phase 2 | 15 Sep 2027Phase 2 trial completes | |||
| Next date | 15 Sep 2027 · Phase 2 trial completes | ||||
| Also tested for | Multiple System Atrophy | ||||
| Open drug page | |||||
Unmodified immunoglobulin |
Teva Branded Pharmaceutical Products R&D · Sanofi |
Phase 2 | — | ||
| How it works | An antibody | ||||
| Also tested for | Crohn Disease, Colitis, Ulcerative | ||||
| Open drug page | |||||
— |
Phase 1 | 26 May 2029Phase 1 trial completes | |||
| Next date | 26 May 2029 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
About
- No active trial
- 6 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021